Edimer Pharmaceuticals

Pierre Fabre is hoping that it can succeed where a host of companies have failed in getting a treatment onto the market for X-linked hypohidrotic ectodermal dysplasia (XLHED), a rare pediatric geneti

A pact with Dermelix Biotherapeutics to co-develop a cure for a rare pediatric genetic disease promises to generate vital funds for advancing EspeRare’s venture philanthropic model to tackle unmet l

Start-Up Execs Adheron Therapeutics Hari Kumar, PhD To: CEO (September) From: CBO, Amira Pharmaceuticals Inc. Phone: 858-926-8155 Akebia Therapeutics Inc. John P. Butler To: Pres. & CEO (Aug

IN VITRO DIAGNOSTICS GeneCentric Diagnostics Inc. GeneCentric raises $5mm through Series A round Molecular diagnostics firm GeneCentric Diagnostics Inc. has raised $5mm from four undisclosed i